Spago Nanomedical AB (SPAGO) — Working Capital to Net Assets Ratio
Spago Nanomedical AB (SPAGO) has a Working Capital to Net Assets ratio of 100.1% as of December 2025. Working capital of Skr30.77 Million (current assets of Skr35.94 Million minus current liabilities of Skr5.17 Million) is measured against net assets of Skr30.75 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See how many days can Spago Nanomedical AB fund operations to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Spago Nanomedical AB Working Capital to Net Assets (2011–2025)
This chart shows how Spago Nanomedical AB's Working Capital to Net Assets ratio has evolved across 15 annual periods from 2011 to 2025. As of December 2025, the ratio stands at 100.1%, reflecting working capital of Skr30.77 Million against net assets of Skr30.75 Million SEK. For the complete balance sheet picture, see Spago Nanomedical AB asset portfolio.
Annual Working Capital to Net Assets for Spago Nanomedical AB (2011–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Spago Nanomedical AB from 2011 to 2025, covering 15 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check asset resilience ratio of Spago Nanomedical AB to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (SEK) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 100.1% | Skr30.77 Million | Skr30.75 Million | Skr35.94 Million | Skr5.17 Million | ▲ +1.6 pp |
| 2024 | 98.5% | Skr32.72 Million | Skr33.23 Million | Skr38.59 Million | Skr5.86 Million | ▲ +0.6 pp |
| 2023 | 97.9% | Skr40.43 Million | Skr41.32 Million | Skr51.91 Million | Skr11.48 Million | ▲ +69.2 pp |
| 2022 | 28.6% | Skr56.45 Million | Skr197.16 Million | Skr65.24 Million | Skr8.80 Million | ▲ +2.9 pp |
| 2021 | 25.7% | Skr47.58 Million | Skr184.81 Million | Skr54.39 Million | Skr6.81 Million | ▲ +9.0 pp |
| 2020 | 16.7% | Skr26.69 Million | Skr159.67 Million | Skr29.83 Million | Skr3.15 Million | ▲ +9.0 pp |
| 2019 | 7.8% | Skr10.67 Million | Skr137.63 Million | Skr13.58 Million | Skr2.91 Million | ▼ -3.0 pp |
| 2018 | 10.7% | Skr13.12 Million | Skr122.22 Million | Skr17.21 Million | Skr4.10 Million | ▼ -14.5 pp |
| 2017 | 25.2% | Skr27.16 Million | Skr107.78 Million | Skr30.98 Million | Skr3.81 Million | ▲ +4.4 pp |
| 2016 | 20.8% | Skr14.96 Million | Skr71.84 Million | Skr17.14 Million | Skr2.18 Million | ▼ -8.0 pp |
| 2015 | 28.8% | Skr18.85 Million | Skr65.41 Million | Skr22.39 Million | Skr3.54 Million | ▲ +5.7 pp |
| 2014 | 23.1% | Skr12.96 Million | Skr56.05 Million | Skr15.02 Million | Skr2.06 Million | ▲ +7.1 pp |
| 2013 | 16.0% | Skr6.12 Million | Skr38.18 Million | Skr8.17 Million | Skr2.05 Million | ▼ -24.5 pp |
| 2012 | 40.6% | Skr17.14 Million | Skr42.25 Million | Skr22.48 Million | Skr5.33 Million | ▲ +38.3 pp |
| 2011 | 2.3% | Skr297.00K | Skr12.84 Million | Skr1.59 Million | Skr1.29 Million | — |